{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:02:46Z","timestamp":1781535766552,"version":"3.54.5"},"reference-count":17,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"DOI":"10.25122\/jml-2023-0257","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T04:02:03Z","timestamp":1724040123000},"page":"87-98","source":"Crossref","is-referenced-by-count":7,"title":["Novel anthraquinone amide derivatives as potential Glyoxalase-I inhibitors"],"prefix":"10.25122","volume":"17","author":[{"given":"Qosay","family":"Al-Balas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science & Technology, Irbid, Jordan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al-Akeedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman, Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal","family":"Najdawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman, Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Bashar","family":"Al-Qazzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soha Taher","family":"Telfah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmaceutical Sciences, Faculty of Pharmacy, Philadelphia University, Amman, Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","published-online":{"date-parts":[[2024,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-015-0321-5","article-title":"Apoptosis, autophagy, necroptosis, and cancer metastasis","volume":"14","author":"Su Z, Yang Z, Xu Y, Chen Y, Yu Q","year":"2015","unstructured":"1. Su Z, Yang Z, Xu Y, Chen Y, Yu Q, Apoptosis, autophagy, necroptosis, and cancer metastasis, Mol Cancer, 2015;1448","journal-title":"Mol Cancer"},{"issue":"6","key":"ref2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A","year":"2018","unstructured":"2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 2018;68(6):394-424","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"ref3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0006-291x6990445-8","article-title":"Glyoxalase inhibitors as potential anticancer agents","volume":"35","author":"Vince R, Wadd WB","year":"1969","unstructured":"3. Vince R, Wadd WB, Glyoxalase inhibitors as potential anticancer agents, Biochem Biophys Res Commun, 1969;35(5):593-8","journal-title":"Biochem Biophys Res Commun"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1021\/jm00283a009","article-title":"Glyoxalase inhibitors. A possible approach to anticancer agents","volume":"14","author":"Vince R, Daluge S","year":"1971","unstructured":"4. Vince R, Daluge S, Glyoxalase inhibitors. A possible approach to anticancer agents, J Med Chem, 1971;1435-37","journal-title":"J Med Chem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0021-9258(18)56017-8","article-title":"The mechanism of action of Glyoxalase","volume":"190","author":"Racker E","year":"1951","unstructured":"5. Racker E, The mechanism of action of Glyoxalase, J Biol Chem, 1951;190685-696","journal-title":"J Biol Chem"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/0272-0590(91)90162-W","article-title":"The Glyoxalase enigma. The biological consequences of a ubiquitous enzyme","volume":"14","author":"Carrington SJ","year":"1986","unstructured":"6. Carrington SJ, The Glyoxalase enigma. The biological consequences of a ubiquitous enzyme, IRCS Med Sci, 1986;14763-768","journal-title":"IRCS Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj2690001","article-title":"The Glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life","volume":"269","author":"Thornalley PJ","year":"1990","unstructured":"7. Thornalley PJ, The Glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life, Biochem J, 1990;2691","journal-title":"Biochem J"},{"issue":"1","key":"ref8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20121743","article-title":"The Glyoxalase pathway: the first hundred years\u2026 and beyond","volume":"453","author":"Sousa Silva M, Gomes RA, Ferreira AEN, Ponces Freire A, Cordeiro C","year":"2013","unstructured":"8. Sousa Silva M, Gomes RA, Ferreira AEN, Ponces Freire A, Cordeiro C, The Glyoxalase pathway: the first hundred years\u2026 and beyond, Biochem J, 2013;453(1):1-15","journal-title":"Biochem J"},{"issue":"Pt 6","key":"ref9","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1042\/bst0311343","article-title":"Glyoxalase I\u2013structure, function and a critical role in the enzymatic defence against glycation","volume":"31","author":"Thornalley PJ","year":"2003","unstructured":"9. Thornalley PJ, Glyoxalase I\u2013structure, function and a critical role in the enzymatic defence against glycation, Biochem Soc Trans, 2003;31(Pt 6):1343-8","journal-title":"Biochem Soc Trans"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"13740","DOI":"10.3390\/molecules171213740","article-title":"Generation of the first structure-based pharmacophoric model containing a selective \u201czinc binding group\u201d feature to identify potential glyoxalase-1 inhibitors","volume":"17","author":"Al-Balas Q, Hassan M, Al-Oudat B, Alzoubi H, Mhaidat N, Almaaytah A","year":"2012","unstructured":"10. Al-Balas Q, Hassan M, Al-Oudat B, Alzoubi H, Mhaidat N, Almaaytah A, Generation of the first structure-based pharmacophoric model containing a selective \u201czinc binding group\u201d feature to identify potential glyoxalase-1 inhibitors, Molecules, 2012;1713740-13758","journal-title":"Molecules"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1021\/ar9501232","article-title":"Carbonic anhydrase: evolution of the zinc binding site by nature and by design","volume":"29","author":"Christianson DW, Fierke CA","year":"1996","unstructured":"11. Christianson DW, Fierke CA, Carbonic anhydrase: evolution of the zinc binding site by nature and by design, Acc Chem Res, 1996;29331-339","journal-title":"Acc Chem Res"},{"issue":"41","key":"ref12","doi-asserted-by":"publisher","first-page":"13480","DOI":"10.1021\/bi990696c","article-title":"Reaction mechanism of Glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogue","volume":"38","author":"Cameron AD, Ridderstr\u00f6m M, Olin B, Kavarana MJ, Creighton DJ, Mannervik B","year":"1999","unstructured":"12. Cameron AD, Ridderstr\u00f6m M, Olin B, Kavarana MJ, Creighton DJ, Mannervik B, Reaction mechanism of Glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogue, Biochemistry, 1999;38(41):13480-90","journal-title":"Biochemistry"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1093\/emboj\/16.12.3386","article-title":"Crystal structure of human Glyoxalase I-evidence for gene duplication and 3D domain swapping","volume":"16","author":"Cameron AD, Olin B, Ridderstr\u00f6m M, Mannervik B, Jones TA","year":"1997","unstructured":"13. Cameron AD, Olin B, Ridderstr\u00f6m M, Mannervik B, Jones TA, Crystal structure of human Glyoxalase I-evidence for gene duplication and 3D domain swapping, EMBO J, 1997;163386-3395","journal-title":"EMBO J"},{"issue":"13","key":"ref14","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/jcc.10306","article-title":"Detailed analysis of grid-based molecular docking: A case study of CDOCKER-A CHARMm-based MD docking algorithm","volume":"24","author":"Wu G, Robertson DH, Brooks III CL, Vieth M","year":"2003","unstructured":"14. Wu G, Robertson DH, Brooks III CL, Vieth M, Detailed analysis of grid-based molecular docking: A case study of CDOCKER-A CHARMm-based MD docking algorithm, J Comput Chem, 2003;24(13):1549-62","journal-title":"J Comput Chem"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejmech.2019.05.015","article-title":"Synthesis and pharmacological evaluation of novel unsubstituted indole-anthraquinone carboxamide derivatives as potent antihyperlipidemic agents","volume":"176","author":"Al-Najdawi M, Hiari Y, Qirim T, Shattat G, Al-Zweri M, Sheikha GA","year":"2019","unstructured":"15. Al-Najdawi M, Hiari Y, Qirim T, Shattat G, Al-Zweri M, Sheikha GA, Synthesis and pharmacological evaluation of novel unsubstituted indole-anthraquinone carboxamide derivatives as potent antihyperlipidemic agents, Eur J Med Chem, 2019;176117-128","journal-title":"Eur J Med Chem"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.2147\/DDDT.S110997","article-title":"Novel Glyoxalase-I inhibitors possessing a \"zinc-binding feature\" as potential anticancer agents","volume":"10","author":"Al-Balas QA, Hassan MA, Al-Shar'I NA, Mhaidat NM, Almaaytah AM, Al-Mahasneh FM","year":"2016","unstructured":"16. Al-Balas QA, Hassan MA, Al-Shar'I NA, Mhaidat NM, Almaaytah AM, Al-Mahasneh FM, Novel Glyoxalase-I inhibitors possessing a \"zinc-binding feature\" as potential anticancer agents, Drug Des Devel Ther, 2016;102623-9","journal-title":"Drug Des Devel Ther"},{"key":"ref17","first-page":"1324","article-title":"Novel Thiazole Carboxylic Acid Derivatives Possessing a\" Zinc Binding Feature\" as Potential Human Glyoxalase-I Inhibitors","volume":"14","author":"Al-Balas QA, Hassan MA, Al Jabal GA, Al-Shar\u2019i NA, Almaaytah AM, El-Elimat T","year":"2017","unstructured":"17. Al-Balas QA, Hassan MA, Al Jabal GA, Al-Shar\u2019i NA, Almaaytah AM, El-Elimat T, Novel Thiazole Carboxylic Acid Derivatives Possessing a\" Zinc Binding Feature\" as Potential Human Glyoxalase-I Inhibitors, Lett Drug Des Discov, 2017;141324-1334","journal-title":"Lett Drug Des Discov"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2024\/issue-1-2024\/original-article-issue-1-2024\/novel-anthraquinone-amide-derivatives-as-potential-glyoxalase-i-inhibitors\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T04:03:21Z","timestamp":1724040201000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2024\/issue-1-2024\/original-article-issue-1-2024\/novel-anthraquinone-amide-derivatives-as-potential-glyoxalase-i-inhibitors\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["JMedLife-17-087"],"URL":"https:\/\/doi.org\/10.25122\/jml-2023-0257","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}